Biological Skin Substitutes Market Size, Share & Trends Analysis Report By Type (Human Donor Tissue-derived Products, Acellular Animal-derived Products), By Application (Acute Wounds, Chronic Wounds), By End-use, By Region, And Segment Forecasts, 2023 - 2

Biological Skin Substitutes Market Size, Share & Trends Analysis Report By Type (Human Donor Tissue-derived Products, Acellular Animal-derived Products), By Application (Acute Wounds, Chronic Wounds), By End-use, By Region, And Segment Forecasts, 2023 - 2


Biological Skin Substitutes Market Growth & Trends


The global biological skin substitutes market size is expected to reach USD 579.0 million by 2030 and is expected to expand at a CAGR of 8.8 % from 2023 to 2030 based on a new report by Grand View Research, Inc. The increasing prevalence of skin diseases, rising incidence of chronic diseases & trauma emergencies, and increasing consciousness regarding tissue engineering, along with potential pipeline products, are some of the major factors responsible for the growth of tissue nano transfection technology. Furthermore, increasing government and private organizations’ investment in research and development activities is likely to boost the demand for biological skin substitutes.

The COVID-19 pandemic has affected several aspects of the wound care process, which includes compliance with wound care visits, triggering alternative approaches such as the use of virtual care platforms or telemedicine and streaming videos on the social media platform to assist the patients with wound dressing and empowering a do-it-yourself wound dressing approach. There is an increasing desire to understand how the social dimensions of health impact the Quality of Life (QoL) and effectiveness of wound care patients. The direct consequence of such changes in health care is the disruption of the continuity of wound care in several ways. However, these changes have negatively impacted wound outcomes but also have driven the development of a virtual-based approach for patient visits.

The key companies in the market are attempting to improve their portfolio by upgrading their products, employing significant cooperative efforts, and considering acquisitions and government permissions to increase their client base and capture a larger share of the biological skin substitutes market.

Biological Skin Substitutes Market Report Highlights

  • Based on type, the human donor tissue-derived products segment accounted for the largest market share of 66.9% in 2022 as it allows better integration and acceptance by the patient's body
  • Based on application, the chronic wounds segment is expected to witness the fastest growth, with a CAGR of 9.0% over the forecast period due to the increasing prevalence of chronic wounds
  • Based on end-use, the hospital segment dominated the biological skin substitutes market with a revenue share of 54.8% in 2022. The outpatient facilities segment is expected to witness the fastest CAGR of 8.9% over the forecast period owing to the shorter wait times and more flexible scheduling options
  • North America accounted for the largest revenue share of nearly 42% in 2022 owing to the presence of major companies in the region
Please note The report will be delivered in 3-8 business days upon order notification.


Chapter 1 Report Scope And Objectives
1.1 Market Segmentation & Scope
1.2 Regional Scope
1.2.1 Estimates And Forecast Timeline
1.3 Objectives
1.3.1 Objective - 1
1.3.2 Objective - 2
1.3.3 Objective - 3
Chapter 2 Methodology
2.1 Research Methodology
2.2 Information Procurement
2.2.1 Purchased Database
2.2.2 Gvr’s Internal Database
2.2.3 Secondary Sources
2.2.4 Primary Research
2.3 Information Or Data Analysis
2.3.1 Data Analysis Models
2.4 Market Formulation & Validation
2.5 Model Details
2.5.1 Commodity Flow Analysis (Model 1)
2.5.2 Volume Price Analysis (Model 2)
2.6 List Of Secondary Sources
Chapter 3 Executive Summary
3.1 Market Outlook
3.2 Segment Outlook
3.2.1 Type
3.2.2 Application
3.2.3 End-Use
3.2.4 Region
3.3 Competitive Insights
3.4 Biological Skin Substitutes Market Outlook, 2022
Chapter 4 Market Variables, Trends & Scope
4.1 Market Lineage Outlook
4.1.1 Parent Market Outlook
4.2 Biological Skin Substitutes Market Dynamics
4.2.1 Market Driver Analysis
4.2.1.1 Increase In The Prevalence Of Chronic Wounds And Increasing Burn & Trauma Cases Globally
4.2.1.2 Increasing Demand For Affordable Skin-Replacement Solutions
4.2.3 Market Restraint Analysis
4.2.2.1 High Cost Of Biological Products For Wound Care
4.3 Biological Skin Substitutes Market: Business Environment Analysis Tools
4.3.1 Porter’s Five Forces Analysis
4.3.1.1 Threat Of New Entrants
4.3.1.2 Bargaining Power Of Suppliers
4.3.1.3 Bargaining Power Of Buyer
4.3.1.4 Competitive Rivalry
4.3.1.5 Threat Of Substitutes
4.3.2 Pestel Analysis
4.3.2.1 Political & Legal
4.3.2.2 Economic & Social
4.3.2.3 Technological
4.4 Penetration & Growth Prospect Mapping
4.5 Technology Trend Analysis
4.6 Regulatory Framework
4.7 Impact Of Covid-19 On Biological Skin Substitutes Market
Chapter 5 Biological Skin Substitutes Market: Type Analysis
5.1 Biological Skin Substitutes Type Market Share Analysis, 2022 & 2030
5.2 Biological Skin Substitutes, Type, Market: Segment Dashboard:
5.3 Market Size & Forecasts And Trend Analyses, 2018 To 2030 For Type Segment
5.3.1 Human Donor Tissue-Derived Products
5.3.1.1 Human Donor Tissue-Derived Products Market, 2018 - 2030 (USD Million)
5.3.2 Acellular Animal-Derived Products
5.3.2.1 Acellular Animal-Derived Products Market, 2018 - 2030 (USD Million)
Chapter 6 Biological Skin Substitutes Market: Application Analysis
6.1 Biological Skin Substitutes Application Market Share Analysis, 2022 & 2030
6.2 Biological Skin Substitutes Application Market: Segment Dashboard
6.3 Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Application Segment
6.3.1 Acute Wound
6.3.1.1 Acute Wound Market, 2018 - 2030 (USD Million)
6.3.2 Chronic Wound
6.3.2.1 Chronic Wound Market, 2018 - 2030 (USD Million)
Chapter 7 Biological Skin Substitutes Market: End-Use Analysis
7.1 Biological Skin Substitutes End-Use Market Share Analysis, 2022 & 2030
7.2 Biological Skin Substitutes End-Use Market: Segment Dashboard
7.3 Market Size & Forecasts And Trend Analyses, 2018 To 2030 For End-Use Segment
7.3.1 Hospitals
7.3.1.1 Hospitals Market, 2018 - 2030 (USD Million)
7.3.2 Outpatient Facilities
7.3.2.1 Outpatient Facilities Market, 2018 - 2030 (USD Million)
7.3.3 Research And Manufacturing
7.3.3.1 Research And Manufacturing Market, 2018 - 2030 (USD Million)
Chapter 8 Biological Skin Substitutes Market: Regional Analysis
8.1 Biological Skin Substitutes Regional Market Share Analysis, 2022 & 2030
8.2 Regional Market Snapshot
8.3 North America
8.3.1 North America Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
8.3.2 U.S.
8.3.2.1 U.S. Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
8.3.3 Canada
8.3.3.1 Canada Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
8.4 Europe
8.4.1 Europe Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
8.4.2 U.K.
8.4.2.1 Uk Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
8.4.3 Germany
8.4.3.1 Germany Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
8.4.4 France
8.4.4.1 France Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
8.4.5 Italy
8.4.5.1 Italy Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
8.4.6 Spain
8.4.6.1 Spain Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
8.4.7 Denmark
8.4.7.1 Denmark Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
8.4.8 Sweden
8.4.8.1 Sweden Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
8.4.9 Norway
8.4.9.1 Norway Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
8.5 Asia Pacific
8.5.1 Asia Pacific Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
8.5.2 Japan
8.5.2.1 Japan Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
8.5.3 China
8.5.3.1 China Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
8.5.4 India
8.5.4.1 India Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
8.5.5 Australia
8.5.5.1 Australia Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
8.5.6 Thailand
8.5.6.1 Thailand Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
8.5.7 South Korea
8.5.7.1 South Korea Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
8.6 Latin America
8.6.1 Latin America Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
8.6.2 Brazil
8.6.2.1 Brazil Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
8.6.3 Mexico
8.6.3.1 Mexico Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
8.6.4 Argentina
8.6.4.1 Argentina Biological Skin Substitumarketrket, 2018 - 2030 (USD Million)
8.7 Middle East And Africa (Mea)
8.7.1 Mea Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
8.7.2 South Africa
8.7.2.1 South Africa Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
8.7.3 Saudi Arabia
8.7.3.1 Saudi Arabia Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
8.7.4 Uae
8.7.4.1 Uae Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
8.7.5 Kuwait
8.7.5.1 Kuwait Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
Chapter 9 Competitive Analysis
9.1 Recent Developments & Impact Analysis, By Key Market Participants
9.2 Company Profiles
9.3 Organogenesis, Inc.
9.3.1 Company Overview
9.3.2 Financial Performance
9.3.3 Product Benchmarking
9.3.4 Strategic Initiatives
9.4 3m
9.4.1 Company Overview
9.4.2 Financial Performance
9.4.3 Product Benchmarking
9.4.4 Strategic Initiatives
9.5 Integra Lifesciences
9.5.1 Company Overview
9.5.2 Financial Performance
9.5.3 Product Benchmarking
9.5.4 Strategic Initiatives
9.6 Smith And Nephew
9.6.1 Company Overview
9.6.2 Financial Performance
9.6.3 Product Benchmarking
9.6.4 Strategic Initiatives
9.7 Tissue Regenix
9.7.1 Company Overview
9.7.2 Financial Performance
9.7.3 Product Benchmarking
9.7.4 Strategic Initiatives
9.8 Mimedx
9.8.1 Company Overview
9.8.2 Financial Performance
9.8.3 Product Benchmarking
9.8.4 Strategic Initiatives
9.9 Bsn Medical
9.9.1 Company Overview
9.9.2 Financial Performance
9.9.3 Product Benchmarking
9.9.4 Strategic Initiatives
9.10 Stryker
9.10.1 Company Overview
9.10.2 Financial Performance
9.10.3 Product Benchmarking
9.10.4 Strategic Initiatives
9.11 Vericel Corporation.
9.11.1 Company Overview
9.11.2 Financial Performance
9.11.3 Product Benchmarking
9.11.4 Strategic Initiatives
9.12 Mallinckrodt (Stratatech Corporation)
9.12.1 Company Overview
9.12.2 Financial Performance
9.12.3 Product Benchmarking
9.12.4 Strategic Initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings